ATOME Logo

Welcome

The Access to Opioid Medication in Europe (ATOME) project engages a new consortium of academic institutions and public health organizations in working to help European governments identify and remove barriers that prevent people from accessing medicines that could improve end of life care, alleviate debilitating pain and treat heroin dependence.

With funding from the European Commission's 7th Framework Programme, ten ATOME partners have committed to work with their respective country teams, in addition to government officials, public health and medicine experts from within these countries to conduct legislative and policy reviews.

The outcome of these reviews will lead to recommendations that will facilitate access for all patients requiring treatment with medicines controlled under international drug conventions.

ATOME Events

Conference Registration

Cyprus - 30th May 2012

ATOME Symposium for Improving Access to Opioid Medication in Cyprus
Register now...


Other events

20th November 2012

ATOME One-Day Conference: Greece
Read More...

21st March 2013

ATOME One-Day Conference: Latvia
Read More...

26th April 2013

ATOME One-Day Conference: Hungary
Read More...

ATOME News

No current news

Next ATOME Conference

1 Day Conference:
ATOME Symposium for Improving Access to Opioid Medication in Cyprus

Cyprus

30th May 2012

Click here to take you to the conference information page

Map of 12 Target Countries

ATOME Countries

Countries

The twelve target countries of the Atome project are:

New Guidelines Published

These new World Health Organization (WHO) policy guidelines Ensuring balance in national policies on controlled substances: guidance for availability and accessibility of controlled medicines build on a previous set of guidelines, Achieving balance in national opioids control policy: guidelines for assessment, published in 2000.

In addition to the English language version, you can download a copy in the language of the following nations. Please select the appropriate link from the list below:

Disclaimers:


Map representations are for illustration purposes only and are not accurate representations of national boundaries.

Language translations, where provided, have not been verified. ATOME cannot be held responsible for inaccuracies in the translated word.

The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 222994

© ATOME 2010-2012

Other pages within the site: